胃肠镜镇静相关不良事件(CH-ESC研究):中国三级医院前瞻性观察性队列研究方案
本研究为中国三级医院开展的前瞻性观察性队列研究,计划于2023年11月至2026年11月招募100100例接受镇静胃肠镜的患者,主要结局为操作期间镇静相关不良事件发生率,并通过多因素logistic回归分析识别独立预测因素。截至2024年7月31日已入组6023例,研究团队计划申请延长入组至2028年12月31日。
要点
- 中国三级医院前瞻性观察性队列,计划招募100100例镇静胃肠镜患者。
- 主要结局为操作期间镇静相关不良事件发生率。
- 将多因素logistic回归分析识别独立预测因素。
核心结论
- 本研究旨在评估中国三级医院镇静胃肠镜相关不良事件的发生率、特征及危险因素。
- 研究可能有助于改进风险分层模型和提升患者安全方案。
研究设计与样本
- 前瞻性观察性队列研究,在中国一家三级医院的消化内镜中心开展。
- 计划于2023年11月至2026年11月招募100100例接受镇静胃肠镜的患者。
- 截至2024年7月31日已入组6023例;研究团队计划申请伦理委员会延长入组至2028年12月31日。
- 试验注册:中国临床试验注册中心ChiCTR2300078784,注册日期2023年12月18日;招募于2023年12月1日开始。
主要发现
- 截至2024年7月31日已入组6023例参与者。
- 主要结局为内镜操作期间镇静相关不良事件的发生率。
关键数值与推荐
- 主要结局为内镜操作期间镇静相关不良事件的发生率。
- 将收集患者人口学(如年龄、BMI)、镇静参数(如所用药物、镇静深度)及内镜操作特征(如类型和持续时间)等候选因素,进入多因素logistic回归分析以识别独立预测因素。
- 除已确立的危险因素外,本研究拟探索新兴预测因素,包括腰臀比和衰弱评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出这是一项单中心研究。
- 原文指出门诊性质和操作持续时间短使准确报告复杂化,可能导致镇静相关不良事件被低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sedation is commonly employed during gastrointestinal endoscopy (GIE), yet sedation-related adverse events (SRAEs)-particularly cardiopulmonary complications-remain a critical safety concern. While large cohort studies from Western countries have identified key risk factors such as advanced age, obesity, and high ASA classification, data on SRAEs within the Chinese population are scarce. This study aims to assess the prevalence, characteristics, and risk factors associated with SRAEs in a Chinese tertiary hospital setting. METHODS/DESIGN: This prospective, observational cohort study is being conducted at the Changhai Digestive Endoscopy Center, one of the largest GIE facilities in China. Between November 2023 and November 2026, we aim to recruit 100,100 patients undergoing sedated GIE. The primary outcome is the incidence of SRAEs during the endoscopy procedure. Comprehensive data on patient demographics (e.g., age, BMI), sedation parameters (e.g., medications used, sedation depth), and endoscopic procedure specifics (e.g., type and duration) will be collected, and these candidate factors will be entered into multivariate logistic regression analysis to identify independent predictors of SRAEs. DISCUSSION: With the increasing application of sedation during GIE, preventing and managing SRAEs is of paramount importance. The outpatient nature and short duration of these procedures complicate accurate reporting, potentially leading to an underestimation of SRAEs. Beyond established risk factors, this study seeks to explore emerging predictors, including waist-to-hip ratio and frailty assessments. Although this is a single-center study, it represents the first large-scale investigation of SRAEs in China and may contribute to improved risk stratification models and enhanced patient safety protocols. TRIAL REGISTRATION: Chinese Clinical Trial Register, ChiCTR2300078784. Registered on December 18, 2023. STUDY STATUS: Recruitment began on December 1, 2023. As of July 31, 2024, 6023 participants have been enrolled. The study team plans to request an extension from the Ethics Committee to continue enrolment until December 31, 2028.
引用
- Lu J, Li B, Yan S, et al. Sedation-related adverse events in gastrointestinal endoscopy (CH-ESC study): study protocol for a prospective, observational cohort study in a Chinese tertiary hospital. Trials. 2025. PMID: 40999444. doi:10.1186/s13063-025-09107-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。